Galderma launches two new dermal fillers

Galderma receives FDA approval for Restylane Refyne and Defyne, two next-generation HA fillers. Read More

FEATURE

Patient preference: Male vs female surgeons

Do cosmetic patients have a gender preference when choosing a surgeon? Researchers Answer

Survey reveals tattoo and tattoo removal behaviors

Do you offer tattoo removal? If so, understanding these patient motivations and barriers will benefit your practice. Read More

Rapamycin may slow aging

Used as a transplant rejection inhibitor, therapy for renal cell carcinoma and as a stent coating, the rapamycin compound may also increase lifespan. Learn More

TRENDING NOW

Biggest anti-aging a-ha's of 2016

The circles of prominence — revisited

Aesthetic tech in 2016

January 6, 2017

We are inviting members of our community to join our Reader Reactor Panel. This select group of individuals will help our brand keep the pulse on important issues facing you and your colleagues today.
Would you like to be involved?

We want to hear from you!

Have comments or questions about the eNewsletter? Contact Cosmetic Surgery Times Aesthetics editor Eliza Cabana at [email protected]

Get the free app from our sister publication!

Part of the

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply.
Please use the links provided if you have questions or concerns regarding this email or your subscription.

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us